1h Free Analyst Time
The in-vitro diagnostics instruments market is poised to grow by $48.3 billion during 2023-2027, accelerating at a CAGR of 9.18% during the forecast period. The market is driven by the growing geriatric population, demand for personalized medicines, and product launches.Speak directly to the analyst to clarify any post sales queries you may have.
This report on the in-vitro diagnostics instruments market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment.
The in-vitro diagnostics instruments market is segmented as below:
By Product
- Immunochemistry
- Clinical Microbiology
- Molecular diagnostics
- Others
By End-user
- Hospitals and diagnostic laboratories
- Academic and research institutes
- Home care
By Geography
- North America
- Europe
- Asia
- Rest of World (ROW)
This report on the in-vitro diagnostics instruments market covers the following areas:
- In-vitro diagnostics instruments market sizing
- In-vitro diagnostics instruments market forecast
- In-vitro diagnostics instruments market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The analyst presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The analyst's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Executive Summary
The analyst recognizes the following companies as the key players in the global in-vitro diagnostics instruments market: Abbott Laboratories, Beijing Leadman Biochemistry Technology Co. Ltd., bioMerieux SA, Biosino Bio-Technology and Science Inc., CPC Diagnostics Pvt Ltd., DAAN Gene Co. Ltd., Danaher Corp., F. Hoffmann La Roche Ltd., Guangzhou Wondfo Biotech Co. Ltd., Myriad Genetics Inc., Ortho Clinical Diagnostics, Shanghai Kehua Bio-Engineering Co. Ltd., Shenzhen Mindray BioMedical Electronics, Siemens AG, Thermo Fisher Scientific Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Hologic Inc., QIAGEN NV, and Sysmex Corp.Commenting on the report, one of the report's analysts said: 'The latest trend gaining momentum in the market is potential opportunities for physician office laboratories (POL).'
According to the report, one of the major drivers for this market is the growing geriatric population.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Beijing Leadman Biochemistry Technology Co. Ltd.
- bioMerieux SA
- Biosino Bio Technology and Science Inc.
- CPC Diagnostics Pvt Ltd.
- DAAN Gene Co. Ltd.
- Danaher Corp.
- F. Hoffmann La Roche Ltd.
- Guangzhou Wondfo Biotech Co. Ltd.
- Myriad Genetics Inc.
- Ortho Clinical Diagnostics
- Shanghai Kehua Bio Engineering Co. Ltd.
- Shenzhen Mindray BioMedical Electronics
- Siemens AG
- Thermo Fisher Scientific Inc.
- Becton Dickinson and Co.
- Bio Rad Laboratories Inc.
- Hologic Inc.
- QIAGEN NV
- Sysmex Corp.